Security key
868459108
SUPERNUS PHARMACEUTICALS, INC. - Common Stock (SUPN)
CUSIP: 868459108
Q4 2023 13F Holders as of 31 Dec 2023
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 57,671,650
- Total 13F shares
- 57,120,264
- Share change
- +570,747
- Total reported value
- $1,653,064,952
- Put/Call ratio
- 93%
- Price per share
- $28.94
- Number of holders
- 244
- Value change
- +$17,403,885
- Number of buys
- 109
- Number of sells
- 112
Report period
Q4 2023
Institutions
244
Top holders
10
SUPN full security history
Newer quarter: Q1 2024
Previous quarter: Q3 2023
SUPERNUS PHARMACEUTICALS, INC. SEC filings
SUPERNUS PHARMACEUTICALS, INC. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 868459108
Recent filing periods:
Top shareholders of SUPN - SUPERNUS PHARMACEUTICALS, INC. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BlackRock Finance, Inc. |
13F
|
Company |
18%
|
10,179,905
|
$280,659,981 | — | 30 Sep 2023 | |
| VANGUARD GROUP INC |
13F
|
Company |
11%
|
6,072,180
|
$167,410,003 | — | 30 Sep 2023 | |
| ARMISTICE CAPITAL, LLC |
13F
|
Company |
8.8%
|
5,092,000
|
$140,386,440 | — | 30 Sep 2023 | |
| MACQUARIE GROUP LTD |
13F
|
Company |
4.8%
|
2,750,856
|
$75,841,000 | — | 30 Sep 2023 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
4%
|
2,314,783
|
$63,820,311 | — | 30 Sep 2023 | |
| STATE STREET CORP |
13F
|
Company |
3.3%
|
1,917,010
|
$52,851,966 | — | 30 Sep 2023 | |
| LOOMIS SAYLES & CO L P |
13F
|
Company |
3%
|
1,730,269
|
$47,703,000 | — | 30 Sep 2023 | |
| Stephens Investment Management Group LLC |
13F
|
Company |
3%
|
1,704,698
|
$46,998,524 | — | 30 Sep 2023 | |
| Polar Capital Holdings Plc |
13F
|
Company |
2.9%
|
1,654,470
|
$45,613,738 | — | 30 Sep 2023 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
2.5%
|
1,438,422
|
$39,657,000 | — | 30 Sep 2023 | |
| GW&K Investment Management, LLC |
13F
|
Company |
2.4%
|
1,406,158
|
$38,768,000 | — | 30 Sep 2023 | |
| Aristotle Capital Boston, LLC |
13F
|
Company |
2.1%
|
1,187,981
|
$32,752,634 | — | 30 Sep 2023 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.9%
|
1,093,097
|
$30,140,605 | — | 30 Sep 2023 | |
| Pictet Asset Management Holding SA |
13F
|
Company |
1.6%
|
920,552
|
$25,379,619 | — | 30 Sep 2023 | |
| CONGRESS ASSET MANAGEMENT CO |
13F
|
Company |
1.6%
|
917,164
|
$25,286,211 | — | 30 Sep 2023 | |
| ASHFORD CAPITAL MANAGEMENT INC |
13F
|
Company |
1.6%
|
916,747
|
$25,274,715 | — | 30 Sep 2023 | |
| NORTHERN TRUST CORP |
13F
|
Company |
1.3%
|
734,150
|
$20,240,516 | — | 30 Sep 2023 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
1.2%
|
711,169
|
$19,606,930 | — | 30 Sep 2023 | |
| Invesco Ltd. |
13F
|
Company |
1.2%
|
682,691
|
$18,821,791 | — | 30 Sep 2023 | |
| Bellevue Group AG |
13F
|
Company |
1%
|
580,600
|
$16,007,142 | — | 30 Sep 2023 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.99%
|
569,019
|
$15,687,854 | — | 30 Sep 2023 | |
| RICE HALL JAMES & ASSOCIATES, LLC |
13F
|
Company |
0.94%
|
544,468
|
$15,010,983 | — | 30 Sep 2023 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.92%
|
531,246
|
$14,646,452 | — | 30 Sep 2023 | |
| MORGAN STANLEY |
13F
|
Company |
0.92%
|
528,579
|
$14,572,922 | — | 30 Sep 2023 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.83%
|
477,380
|
$13,163,000 | — | 30 Sep 2023 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.79%
|
455,927
|
$12,569,908 | — | 30 Sep 2023 | |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC |
13F
|
Company |
0.74%
|
426,500
|
$11,754,340 | — | 30 Sep 2023 | |
| Epoch Investment Partners, Inc. |
13F
|
Company |
0.67%
|
387,653
|
$10,687,593 | — | 30 Sep 2023 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.65%
|
375,826
|
$10,361,522 | — | 30 Sep 2023 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.62%
|
355,002
|
$9,787,405 | — | 30 Sep 2023 | |
| Tributary Capital Management, LLC |
13F
|
Company |
0.61%
|
352,429
|
$9,716,468 | — | 30 Sep 2023 | |
| MUTUAL OF AMERICA CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.6%
|
346,115
|
$9,542,391 | — | 30 Sep 2023 | |
| PRINCIPAL FINANCIAL GROUP INC |
13F
|
Company |
0.53%
|
303,780
|
$8,375,215 | — | 30 Sep 2023 | |
| NORGES BANK |
13F
|
Company |
0.52%
|
297,288
|
$8,196,230 | — | 30 Sep 2023 | |
| SCOUT INVESTMENTS, INC. |
13F
|
Company |
0.5%
|
286,829
|
$7,778,802 | — | 30 Sep 2023 | |
| SEI INVESTMENTS CO |
13F
|
Company |
0.46%
|
267,274
|
$7,368,981 | — | 30 Sep 2023 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.4%
|
230,592
|
$6,357,421 | — | 30 Sep 2023 | |
| Integral Health Asset Management, LLC |
13F
|
Company |
0.38%
|
220,000
|
$6,065,400 | — | 30 Sep 2023 | |
| S&T BANK/PA |
13F
|
Company |
0.37%
|
215,578
|
$5,943,000 | — | 30 Sep 2023 | |
| FRONTIER CAPITAL MANAGEMENT CO LLC |
13F
|
Company |
0.35%
|
200,653
|
$5,532,003 | — | 30 Sep 2023 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.34%
|
196,100
|
$5,406,477 | — | 30 Sep 2023 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.29%
|
166,544
|
$4,591,588 | — | 30 Sep 2023 | |
| CW Advisors, LLC |
13F
|
Company |
0.28%
|
159,146
|
$4,387,651 | — | 30 Sep 2023 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.27%
|
157,310
|
$4,337,036 | — | 30 Sep 2023 | |
| Phocas Financial Corp. |
13F
|
Company |
0.27%
|
157,066
|
$4,330,000 | — | 30 Sep 2023 | |
| Legal & General Group Plc |
13F
|
Company |
0.26%
|
151,028
|
$4,163,842 | — | 30 Sep 2023 | |
| Parkman Healthcare Partners LLC |
13F
|
Company |
0.24%
|
138,172
|
$3,809,402 | — | 30 Sep 2023 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.23%
|
133,823
|
$3,689,500 | — | 30 Sep 2023 | |
| Swiss National Bank |
13F
|
Company |
0.21%
|
119,700
|
$3,300,129 | — | 30 Sep 2023 | |
| THIRD AVENUE MANAGEMENT LLC |
13F
|
Company |
0.2%
|
116,549
|
$3,272,696 | — | 30 Sep 2023 |
Institutional Holders of SUPERNUS PHARMACEUTICALS, INC. - Common Stock (SUPN) as of Q4 2023
As of 31 Dec 2023,
SUPERNUS PHARMACEUTICALS, INC. - Common Stock (SUPN) was held by
244 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
57,120,264 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, ARMISTICE CAPITAL, LLC, MACQUARIE GROUP LTD, DIMENSIONAL FUND ADVISORS LP, STATE STREET CORP, Polar Capital Holdings Plc, Stephens Investment Management Group LLC, LOOMIS SAYLES & CO L P, and RENAISSANCE TECHNOLOGIES LLC.
This page lists
244
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2023 vs Q3 2023 Across Filers
Q3 2023 holders
235
Q4 2023 holders
244
Holder diff
9
| Investor | Q3 2023 Shares | Q4 2023 Shares | Share Diff | Share Chg % | Q3 2023 Value $ | Q4 2023 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.